First-Ever Pivotal Trial of Synthetic Restorative Pulmonary Heart Valve

Based in Eindhoven, Netherlands, Xeltis is a clinical-stage developer of advanced polymer-based restorative cardiovascular devices. The company has now announced … continue reading “First-Ever Pivotal Trial of Synthetic Restorative Pulmonary Heart Valve”

FDA Approval for Biosense Webster THERMOCOOL SMARTTOUCH® SF Ablation Catheter for Persistent Atrial Fibrillation

Johnson & Johnson Medical Devices Companies have announced the U.S. FDA approval of Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH® SF Ablation … continue reading “FDA Approval for Biosense Webster THERMOCOOL SMARTTOUCH® SF Ablation Catheter for Persistent Atrial Fibrillation”

First Scoring Guidelines Validated for WatchPAT™ Sleep Apnea Diagnostic

Respiratory Sleep Disorder specialist, Itamar Medical Ltd. has announced publication of results of the COMPASS study. The upshot sees validated … continue reading “First Scoring Guidelines Validated for WatchPAT™ Sleep Apnea Diagnostic”

Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment

Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve replacement (TAVR), has announced completion of enrollment in its … continue reading “Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment”

Glenfield to become one of first UK Hospitals to offer Boston Scientific’s WATCHMAN FLX™

Leicester’s Glenfield Hospital is to introduce the latest stroke-preventing cardiac implant, through Althea’s Consumable Management Service (CMS). Background Atrial fibrillation … continue reading “Glenfield to become one of first UK Hospitals to offer Boston Scientific’s WATCHMAN FLX™”

Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include Itamar WatchPAT™ in Their Policies

Non-invasive diagnostic sleep apnea device expert Itamar Medical Ltd. has announced that Blue Shield of California (BSC) and the Blue … continue reading “Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include Itamar WatchPAT™ in Their Policies”

Limited Release of BioCardia AVANCE™ Steerable CV Catheter Introducer

Following its recent FDA clearance, BioCardia, Inc. has confirmed the U.S. commercial availability of the AVANCE™ Bi-Directional Steerable Introducer Sheath for introducing … continue reading “Limited Release of BioCardia AVANCE™ Steerable CV Catheter Introducer”